Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) advises that as part of its planned board renewal, Nick Burrows has resigned as an independent non-executive director, effective today.
The company — a global leader in genomics-based tests in health, wellness and serious disease — is in the process of further strengthening the board through the impending appointment of two incoming directors, one of whom is a resident in the USA with extensive consumer marketing experience in the women’s health area. The board is concurrently approving an extensive DTC sales campaign in the USA.